Stay updated on Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page footer now identifies the site as revision v3.8.0 instead of v3.7.2; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide NIH notice announces transition updates and says some content may use “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI).SummaryDifference1%

- Check24 days agoChange DetectedThe site footer’s displayed revision changed from v3.7.1 to v3.7.2 while the page continued to show a 403 error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site revision identifier in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page displays a 403 Forbidden message, and the detailed study content is no longer visible, indicating access to the study record is blocked.SummaryDifference18%

- Check52 days agoChange DetectedThe page now lists revision v3.7.0, replacing the previous v3.6.6. This reflects an updated version of the study protocol and statistical analysis plan in the documents section.SummaryDifference0.1%

Stay in the know with updates to Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.